| Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals X Ying, HE Wen, WL Lu, J Du, J Guo, W Tian, Y Men, Y Zhang, RJ Li, ... Journal of Controlled Release 141 (2), 183-192, 2010 | 505 | 2010 |
| The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in … XX Wang, YB Li, HJ Yao, RJ Ju, Y Zhang, RJ Li, Y Yu, L Zhang, WL Lu Biomaterials 32 (24), 5673-5687, 2011 | 209 | 2011 |
| Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood− brain barrier and survival of brain … J Du, WL Lu, X Ying, Y Liu, P Du, W Tian, Y Men, J Guo, Y Zhang, RJ Li, ... Molecular pharmaceutics 6 (3), 905-917, 2009 | 181 | 2009 |
| The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery HJ Yao, RJ Ju, XX Wang, Y Zhang, RJ Li, Y Yu, L Zhang, WL Lu Biomaterials 32 (12), 3285-3302, 2011 | 175 | 2011 |
| Structural basis of arc binding to synaptic proteins: implications for cognitive disease W Zhang, J Wu, MD Ward, S Yang, YA Chuang, M Xiao, R Li, DJ Leahy, ... Neuron 86 (2), 490-500, 2015 | 153 | 2015 |
| Regulation of mTORC1 by lysosomal calcium and calmodulin RJ Li, J Xu, C Fu, J Zhang, YG Zheng, H Jia, JO Liu Elife 5, e19360, 2016 | 149 | 2016 |
| Mitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapsed breast cancer arising from cancer stem cells L Zhang, HJ Yao, Y Yu, Y Zhang, RJ Li, RJ Ju, XX Wang, MG Sun, JF Shi, ... Biomaterials 33 (2), 565-582, 2012 | 140 | 2012 |
| All-trans retinoic acid stealth liposomes prevent the relapse of breast cancer arising from the cancer stem cells RJ Li, X Ying, Y Zhang, RJ Ju, XX Wang, HJ Yao, Y Men, W Tian, Y Yu, ... Journal of controlled release 149 (3), 281-291, 2011 | 139 | 2011 |
| Antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cells SA Head, W Shi, L Zhao, K Gorshkov, K Pasunooti, Y Chen, Z Deng, R Li, ... Proceedings of the National Academy of Sciences 112 (52), E7276-E7285, 2015 | 118 | 2015 |
| Mitochondrial targeting topotecan-loaded liposomes for treating drug-resistant breast cancer and inhibiting invasive metastases of melanoma Y Yu, ZH Wang, L Zhang, HJ Yao, Y Zhang, RJ Li, RJ Ju, XX Wang, ... Biomaterials 33 (6), 1808-1820, 2012 | 99 | 2012 |
| First quantitative high-throughput screen in zebrafish identifies novel pathways for increasing pancreatic β-cell mass G Wang, SK Rajpurohit, F Delaspre, SL Walker, DT White, A Ceasrine, ... Elife 4, e08261, 2015 | 98 | 2015 |
| Enhanced efficacy of functionalized epirubicin liposomes in treating brain glioma-bearing rats W Tian, X Ying, J Du, J Guo, Y Men, Y Zhang, RJ Li, HJ Yao, JN Lou, ... European journal of pharmaceutical sciences 41 (2), 232-243, 2010 | 88 | 2010 |
| Simultaneous targeting of NPC1 and VDAC1 by itraconazole leads to synergistic inhibition of mTOR signaling and angiogenesis SA Head, WQ Shi, EJ Yang, BA Nacev, SY Hong, KK Pasunooti, RJ Li, ... ACS chemical biology 12 (1), 174-182, 2017 | 74 | 2017 |
| Pharmacological blockade of cholesterol trafficking by cepharanthine in endothelial cells suppresses angiogenesis and tumor growth J Lyu, EJ Yang, SA Head, N Ai, B Zhang, C Wu, RJ Li, Y Liu, C Yang, ... Cancer letters 409, 91-103, 2017 | 58 | 2017 |
| Effects of stealth liposomal daunorubicin plus tamoxifen on the breast cancer and cancer stem cells J Guo, WL Lu Journal of Pharmacy & Pharmaceutical Sciences 13 (2), 136-151, 2010 | 58 | 2010 |
| Inositol hexakisphosphate kinase-3 regulates the morphology and synapse formation of cerebellar purkinje cells via spectrin/adducin C Fu, J Xu, RJ Li, JA Crawford, AB Khan, TM Ma, JY Cha, AM Snowman, ... Journal of Neuroscience 35 (31), 11056-11067, 2015 | 51 | 2015 |
| Targeting therapy with mitosomal daunorubicin plus amlodipine has the potential to circumvent intrinsic resistant breast cancer Y Zhang, RJ Li, X Ying, W Tian, HJ Yao, Y Men, Y Yu, L Zhang, RJ Ju, ... Molecular pharmaceutics 8 (1), 162-175, 2011 | 51 | 2011 |
| FDA approval summary: calaspargase pegol-mknl for treatment of acute lymphoblastic leukemia in children and young adults RJ Li, R Jin, C Liu, X Cao, ML Manning, XM Di, D Przepiorka, F Namuswe, ... Clinical cancer research 26 (2), 328-331, 2020 | 36 | 2020 |
| Role of model‐informed drug development in pediatric drug development, regulatory evaluation, and labeling Y Bi, J Liu, L Li, J Yu, A Bhattaram, M Bewernitz, R Li, C Liu, J Earp, L Ma, ... The Journal of Clinical Pharmacology 59, S104-S111, 2019 | 34 | 2019 |
| The efficacy of mitochondrial targeting antiresistant epirubicin liposomes in treating resistant leukemia in animals Y Men, XX Wang, RJ Li, Y Zhang, W Tian, HJ Yao, RJ Ju, X Ying, J Zhou, ... International Journal of Nanomedicine, 3125-3137, 2011 | 32 | 2011 |
